Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]
ISIS Rating Summary
ISIS Price Target Summary
- Highest: $152.00 (Roth/MKM)
- Lowest: $152.00 (Roth/MKM)
- Average: $152.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$152.00 (+164.1%)
* Over Last 12-Mos
Rating Score: 4.4 / 10 Percentile Rank: 45%
Rating Score: 4.4 / 10 Percentile Rank: 45%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/18/2015 | Goldman Sachs | N/A | New Coverage | Neutral (N/A) |
65.00 (N/A) |
61.32 (57.56) |
-6.13% | Details |
9/22/2015 | Barclays | N/A | New Coverage | Equalweight (N/A) |
60.00 (N/A) |
50.20 (57.56) |
14.66% | Details |